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ABSTRACT
We introduce a new modeling approach for understanding the fundamental principle of bead-based 
surface coverage immunoassays that rely on the specific interaction between surface-bound “small” 
magnetic beads (1 μm in diameter) and a flow of “large” magnetic beads (3 μm in diameter). The latter 
ones carry target antigens and are simultaneously used as detection labels [1]. This immunoassay 
technique allows attaining extremely low (attomolar) limits of detection, with strongly sub-linear dose-
response curves, but the origin of these features remained unclear up to now. Our comprehensive 
theoretical model allows complete understanding of these unsolved issues. 
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INTRODUCTION
Capturing antigens (Ags) from clinical sample solutions is often performed by using magnetic beads 
functionalized with specific antibodies (Abs) [2]. Ag-carrying beads can be transported to a detection 
surface covered with Abs where quantification is often performed by counting the beads captured on the 
surface via Ab-Ag-Ab immunocomplex bonds [3]. When molecules are tethered to surfaces, their 
immunoreaction kinetics is substantially reduced compared to freely diffusing species [4] and the 
probability of immunocomplex formation becomes an unlikely event. Nevertheless, we experimentally 
observed extremely low (attomolar) limits of detection. Moreover, dose-response curves obtained with 
this assay, as well as with other similar bead-based methods, always show a puzzling non-linear 
dependence on Ag concentration, which was so far unexplained. Here, we introduce a new “random-walk 
based” model, in order to explain the features of this new class of ultrasensitive magnetic bead-based 
immunoassays. 
 
THEORYANDEXPERIMENTAL
The principle of our magnetic bead-based assay is shown in Fig. 1a. An array of Ab-functionalized 
small (? 1 μm) superparamagnetic beads is patterned at the bottom of a microfluidic channel. Large (? 3 
μm) superparamagnetic beads are used to isolate specific Ags from a sample under test. Large beads are 
then injected into the microchannel and transported by the flow, while being magnetophoretically 
attracted onto the detection area. Large beads slide over the substrate and “scan” the functionalized 
surface of the small beads. When carrying an Ag, they can eventually bind to the small beads by forming 
an Ag-Ab-Ag immunocomplex (Fig. 1b). If no Ag is present instead, large beads cannot be retained on 
the array and they are removed by the flow. Simple counting of the number of captured large beads 
provides a measure of the amount of Ag molecules carried by the beads (Fig. 1c). Our modeling approach 
for this kind of assay is based on the concept of “magnetic bead scanning”: each moving large bead, while 
transported by hydrodynamic forces, is actually subjected to successive stochastic reorientations induced 
by magnetic dipolar interactions with the substrate-bound small magnetic beads. This phenomenon can be 
theoretically described as “random walk” of the contact point between an Ag-carrying large bead and the 
small bead pattern. It can be modeled by considering stochastic moves over the surface of the mobile 
bead, until this point coincides with the position of an Ag, hence resulting in the bead capture (Fig. 1d). 
Moreover, the total number of specifically captured beads clearly depends on the amount of large beads 
which are actually scanning the small bead array. This number can be predicted by tridimensional (3D) 
particle tracking simulations, obtained by combining microfluidic and magnetic Finite Element Method 
(FEM) simulations with analytical calculations (Fig. 1e).   
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Figure 1: (a) Schematic representation of the principle of our magnetic bead-based assay. (b) Specific 
immunocomplex formation at the interface between a large and a small bead is responsible for the capture of large 
beads on the array. (c) Counting of the number of captured large particles provides the measure of the Ag 
concentration in the sample under test. (d) Schematic representation of the modeling approach used to describe the 
bead “scanning” phase of the assay: the displacement of the large bead over the small bead array is modeled by 
taking the large bead as reference system and considering a “random walk” of the point of contact between the 
large bead and a pattern of small beads. (e) Schematic representation of the modeling tool developed to describe the 
bead “landing” phase of the assay. The trajectory of a large bead entering the channel at any position can be 
predicted via 3D particle tracking simulations, obtained by combining FEM simulations with analytical 
calculations.   

RESULTSANDDISCUSSION
The extremely low limit of detection attained with this kind of assay can be fully understood by 
considering the probability of single immunocomplex formation, which is dramatically enhanced by the 
bead-scanning mechanism (Fig. 2a-b). When large magnetic beads move in a magnetic field in absence of 
immobilized small beads, the field “pins” their magnetic moment, forcing them to slide over the substrate 
and probe it at one point [5], hence providing a single chance for ligand-receptor binding (modeled as a 
single throw of dices in Fig. 2a, case i). When instead large beads move in presence of both the external 
magnetic field and the small bead array, the contact point describes a different line on the surface of the 
large bead at each bead reorientation. This fact dramatically enhances the chance for successful binding 
(modeled as multiple throws of dices, Fig. 2a, case ii). By calculating the probability of large bead capture 
for both the aforementioned situations and for different bead sizes, we estimated the capture probability 
enhancement introduced by the bead-scanning mechanism (Fig. 2b). By using the random walk-based 
modeling approach, we can then explain and formally predict the particular behavior of the assay dose-
response curves, over a wide range of Ag concentrations and for two distinct ligand-receptor systems: 
biotin – streptavidin (Fig. 2c) and TNF-??– anti TNF-? (Fig. 2d).  
 
CONCLUSION
Because of the pioneering nature of our model in explaining the principle of ultra-low sensitivity 
detection, we believe that the proposed model will represent a powerful tool for the design of novel 
magnetic bead-based immunoassays with potentially unmatched performance and limit of detection. 
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Figure 2: (a) Schematic representation of the bead scanning mechanism, (case i) in absence and (case ii) in 
presence of immobilized small beads. A different section of the large bead surface is explored at each interaction 
with a small particle group, providing higher chance of successful binding, probabilistically modeled as multiple 
throws of dices. (b) Probability of specific capture of single large beads (Pcapture), calculated for the two cases 
reported in Fig. 2a, as function of the radii of large and small beads. (c,d) Experimental results of detection of (c) 
biotinylated anti-streptavidin and (d) TNF-???????????????????????????????????????????????????????????????????[1] 
and fitted according to our model predictions.   
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